Peter Kies insider trades

Open-market stock purchases and sales by Peter Kies, CFO at Inovio Pharmaceuticals, Inc, from SEC Form 4 filings since Mar 11, 2011.

Track record: 83% of 6 scored buys are up 5% or more since purchase, averaging +42%.

Recent trades

DateStockTradeValue
May 20, 2026INO Inovio Pharmaceuticals, IncBought (not open market)—
May 20, 2026INO Inovio Pharmaceuticals, IncSold (not open market)$5.8K
May 20, 2026INO Inovio Pharmaceuticals, IncBought (not open market)—
May 20, 2026INO Inovio Pharmaceuticals, IncBought (not open market)—
May 15, 2026INO Inovio Pharmaceuticals, IncSold (not open market)$3.3K
May 15, 2026INO Inovio Pharmaceuticals, IncBought (not open market)—
Mar 4, 2026INO Inovio Pharmaceuticals, IncBought (not open market)—
Mar 4, 2026INO Inovio Pharmaceuticals, IncBought (not open market)—
Feb 26, 2026INO Inovio Pharmaceuticals, IncSold (not open market)$5.3K
Feb 26, 2026INO Inovio Pharmaceuticals, IncSold (not open market)$11.3K
Feb 26, 2026INO Inovio Pharmaceuticals, IncBought (not open market)—
Feb 26, 2026INO Inovio Pharmaceuticals, IncBought (not open market)—

Companies traded

  • INO Inovio Pharmaceuticals, Inc: 6 buys, 10 sales, last May 20, 2026

Get free alerts when Peter Kies files a new trade →